These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 15340579

  • 1. [Analysis of serological findings and clinical manifestations of TORCH infections in newborns].
    Wang L, Li KH, Liu H, Liu JY, Li YJ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):283-4. PubMed ID: 15340579
    [Abstract] [Full Text] [Related]

  • 2. Seroprevalence of toxoplasma gondii, rubella virus, cytomegalovirus herpes simplex virus (TORCH) and syphilis in Jamaican pregnant women.
    Prabhakar P, Bailey A, Smikle MF, McCaw-Binns A, Ashley D.
    West Indian Med J; 1991 Dec; 40(4):166-9. PubMed ID: 1664562
    [Abstract] [Full Text] [Related]

  • 3. Serological studies on possible causes of intra-uterine infections in Thai infants.
    Tantivanich S, Savanat T, Vongsthongsri U, Manesuwan P.
    Southeast Asian J Trop Med Public Health; 1980 Sep; 11(3):387-94. PubMed ID: 6255610
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Concentrations of the IgM and antibodies for the TORCH complex in the umbilical blood (author's transl)].
    Scalise G, Mura MS, Asara G, Meloni T, Zanetti S, Cappuccinelli P.
    Ann Sclavo; 1977 Sep; 19(5):943-50. PubMed ID: 210726
    [Abstract] [Full Text] [Related]

  • 6. Seroprevalence of TORCH infections in women of childbearing age in Croatia.
    Vilibic-Cavlek T, Ljubin-Sternak S, Ban M, Kolaric B, Sviben M, Mlinaric-Galinovic G.
    J Matern Fetal Neonatal Med; 2011 Feb; 24(2):280-3. PubMed ID: 20476874
    [Abstract] [Full Text] [Related]

  • 7. Screening for TORCH infections in pregnant women: a report from Delhi.
    Kaur R, Gupta N, Nair D, Kakkar M, Mathur MD.
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):284-6. PubMed ID: 10774696
    [Abstract] [Full Text] [Related]

  • 8. [Serological study of cytomegalovirus, herpes simplex and rubella virus, hepatitis B and Toxoplasma gondii in 2 populations of pregnant women in Santiago, Chile].
    Vial P, Torres-Pereyra J, Stagno S, González F, Donoso E, Alford CA, Hirsch T, Rodríguez L.
    Bol Oficina Sanit Panam; 1985 Nov; 99(5):528-38. PubMed ID: 3006719
    [No Abstract] [Full Text] [Related]

  • 9. Antibody prevalence to torch agents in pregnant women and relative risk of congenital infections in Italy (Liguria).
    Canessa A, Pantarotto F, Miletich F, Russo A, Gotta C, Bozzuffi PM, Ferrari G, Fiorelli A, Terragna A.
    Biol Res Pregnancy Perinatol; 1987 Nov; 8(2 2D Half):84-8. PubMed ID: 2827796
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The use of TORCH titers.
    Leland D, French ML, Kleiman MB, Schreiner RL.
    Pediatrics; 1983 Jul; 72(1):41-3. PubMed ID: 6306545
    [Abstract] [Full Text] [Related]

  • 12. How to use... neonatal TORCH testing.
    de Jong EP, Vossen AC, Walther FJ, Lopriore E.
    Arch Dis Child Educ Pract Ed; 2013 Jun; 98(3):93-8. PubMed ID: 23470252
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of antibodies to rubella, herpes simplex 2 and cytomegalovirus in pregnant women and in neonates at Ga-Rankuwa.
    Bos P, Steele D, Alexander J.
    Cent Afr J Med; 1995 Jan; 41(1):14-7. PubMed ID: 7767930
    [Abstract] [Full Text] [Related]

  • 14. TORCH serologies and specific IgM antibody determination in acquired and congenital infections.
    Fung JC, Tilton RC.
    Ann Clin Lab Sci; 1985 Jan; 15(3):204-11. PubMed ID: 2986514
    [Abstract] [Full Text] [Related]

  • 15. TORCH infection in women with bad obstetric history--a pilot study in Kumaon region.
    Thapliyal N, Shukla PK, Kumar B, Upadhyay S, Jain G.
    Indian J Pathol Microbiol; 2005 Oct; 48(4):551-3. PubMed ID: 16366124
    [Abstract] [Full Text] [Related]

  • 16. Is routine TORCH screening warranted in neonates with lenticulostriate vasculopathy?
    de Jong EP, Lopriore E, Vossen AC, Steggerda SJ, Te Pas AB, Kroes AC, Walther FJ.
    Neonatology; 2010 Oct; 97(3):274-8. PubMed ID: 19887856
    [Abstract] [Full Text] [Related]

  • 17. Possible role of TORCH agents in congenital malformations in Gorgan, northern Islamic Republic of Iran.
    Golalipour MJ, Khodabakhshi B, Ghaemi E.
    East Mediterr Health J; 2009 Oct; 15(2):330-6. PubMed ID: 19554979
    [Abstract] [Full Text] [Related]

  • 18. [Preliminary study on ToRCH epidemic laws in Wuhan region].
    Gong Z, Luo L, Xiao H.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun 30; 13(2):139-41. PubMed ID: 12569781
    [Abstract] [Full Text] [Related]

  • 19. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction.
    Yamamoto R, Ishii K, Shimada M, Hayashi S, Hidaka N, Nakayama M, Mitsuda N.
    J Obstet Gynaecol Res; 2013 Mar 30; 39(3):653-7. PubMed ID: 23107457
    [Abstract] [Full Text] [Related]

  • 20. Investigation of congenital infection--the TORCH screen is not a legitimate test. Paediatric Infectious Diseases Group of the Australasian Society for Infectious Diseases.
    Garland SM, Gilbert GL.
    Med J Aust; 1993 Sep 06; 159(5):346-8. PubMed ID: 8395645
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.